Onkologie. 2024:18(1):78-82 | DOI: 10.36290/xon.2024.016

Limberg flap reconstruction after basal cell carcinoma excision

Júlia Bartková1, 2, 3, Dominika Miklišová3, Miroslava Verbat4, Ema Šutaková5, Jana Bartošková6, Iva Tresnerová2, Břetislav Lipový2,3
1 Klinika popáleninové medicíny, 3. lekárska fakulta, Univerzita Karlova, Praha Fakultná nemocnica Královské Vinohrady, Praha
2 Klinika popálenin a plastické chirurgie Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno
3 Lekárska fakulta Masarykovej univerzity, Brno
4 I. lékařská fakulta, Univerzita Karlova, Praha
5 II. lékařská fakulta, Univerzita Karlova, Praha
6 Klinika estetické medicíny a plastické chirurgie, Relief Clinic Znojmo

Basal cell carcinoma (BCC) is the most common skin tumor in fair-skinned people with a constantly increasing worldwide incidence. Patients with BCC represent a great burden on the health care system, because of their high incidence, which constantly increases the costs of the provided health care. It is therefore very important to work on the continuous improvement of preventive programs dedicated to the issue and solving the growing problem of skin cancer.

Keywords: basal cell carcinoma, non melanoma skin cancer, Limberg flap, reconstruction.

Accepted: February 22, 2024; Published: February 28, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartková J, Miklišová D, Verbat M, Šutaková E, Bartošková J, Tresnerová I, Lipový B. Limberg flap reconstruction after basal cell carcinoma excision. Onkologie. 2024;18(1):78-82. doi: 10.36290/xon.2024.016.
Download citation

References

  1. Davies A. The effective management of squamous cell carcinoma. Br J Nurs. 2009;18(9):539-543. doi:10.12968/bjon.2009.18.9.42256. Go to original source... Go to PubMed...
  2. Firnhaber JM. Diagnosis and treatment of Basal cell and squamous cell carcinoma. Am Fam Physician. 2012;86(2):161-168.
  3. Thet Z, Lam AK, Ranganathan D, et al. Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton). 2021;26(11):907-919. Go to original source... Go to PubMed...
  4. Linares MA, Zakaria A, Nizran P. Skin Cancer. Prim Care. 2015;42(4):645-659. Go to original source... Go to PubMed...
  5. Novotvary 2018 ČR, Cancer incidence in the Czech Republic, 2018 [online]. Praha: Ústav zdravotnických informací a statistiky ČR; 2018 [cit.2023-08-14]. Available from: https://www.uzis.cz/res/f/008352/novotvary2018.pdf.
  6. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer [cit. 14. 08. 2023]. Available from: https://gco.iarc.fr/today
  7. Gordon R. Skin cancer: an overview of epidemiology and risk factors. Seminars in oncology nursing 2013;29(3): 160-169. Go to original source... Go to PubMed...
  8. Cummins DL, Cummins JM, Pantle H, et al. Cutaneous malignant melanoma. Mayo Clinic proceedings. 2006;81(4):500-507. Go to original source... Go to PubMed...
  9. Pyne J, Sapkota D, Wong JC. Aggressive basal cell carcinoma: dermatoscopy vascular features as clues to the diagnosis. Dermatol Pract Concept. 2012;2(3):203a02. Go to original source... Go to PubMed...
  10. Tchernev G, Wollina U, Temelkova I. High-Risk Basal Cell Carcinomas of the Head and Neck: Selected Successful Surgical Approach in Three Bulgarian Patients!. Open Access Maced J Med Sci. 2019;7(10):1665-1668. Go to original source... Go to PubMed...
  11. Yalcin O, Sezer E, Kabukcuoglu F, et al. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma. Int J Clin Exp Pathol. 2015;8(11):15448-15453.
  12. McDaniel B, Badri T, Steele RB. Basal Cell Carcinoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022; September 19.
  13. Adult Treatment Editorial Board. PDQ Skin Cancer Treatment. Bethesda, MD: National Cancer Institute. [cit.2023-08-05]. Available from: https://www.cancer.gov/types/skin/patient/skin-treatment-pdq.
  14. Totonchy M, Leffell D. Emerging concepts and recent advances in basal cell carcinoma. F1000Res. 2017;6:2085. Go to original source... Go to PubMed...
  15. Ad Hoc Task Force, Connolly SM, Baker DR, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery [published correction appears in J Am Acad Dermatol. 2015;72(4):748]. J Am Acad Dermatol. 2012;67(4):531-550. Go to original source... Go to PubMed...
  16. Prickett KA, Ramsey ML. Mohs Micrographic Surgery. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2023; April 14.
  17. Quazi SJ, Aslam N, Saleem H, et al. Surgical Margin of Excision in Basal Cell Carcinoma: A Systematic Review of Literature. Cureus. 2020;12(7):e9211. Go to original source... Go to PubMed...
  18. Morgan FC, Ruiz ES, Karia PS, et al. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol. 2020;83(3):832-838. Go to original source... Go to PubMed...
  19. Kopf AW, Bart RS, Schrager D. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol. 1977;113(4):439-443. Go to original source...
  20. Aydin OE, Tan O, Algan S, et el. Versatile use of rhomboid flaps for closure of skin defects. The Eurasian journal of medicine, 2011;43(1):1-8. Go to original source... Go to PubMed...
  21. Kang AS, Kang KS. Rhomboid flap: Indications, applications, techniques and results. A comprehensive review. Ann Med Surg (Lond). 2021;68:102544. Go to original source... Go to PubMed...
  22. Nemet AY, Deckel, Y, Martin PA, et al. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol. 2006;142(2):293-297. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.